Journal Article

FZJ-2021-04522

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png (+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer’s disease and healthy controls

Tiepolt, S. (Corresponding author) ; Becker, G.-A. ; Wilke, S. ; Cecchin, D. ; Rullmann, M. ; Meyer, P. M. ; Barthel, H. ; Hesse, S. ; Patt, M. ; Luthardt, J. ; Wagenknecht, G.FZJ* ; Sattler, B. ; Deuther-Conrad, W. ; Ludwig, F.-A. ; Fischer, S. ; Gertz, H.-J. ; Smits, R. ; Hoepping, A. ; Steinbach, J. ; Brust, P. ; Sabri, O.

2021
Springer-Verl. Heidelberg [u.a.]

This record in other databases:      

Please use a persistent id in citations: http://hdl.handle.net/2128/30705  doi:10.1007/s00259-020-05029-w

---

Contributing Institute(s):

1. Zentralinstitut für Elektronik (ZEA-2)

Research Program(s):

1. 5253 - Neuroimaging (POF4-525) (POF4-525)
2. NikotinPET - Validierung von (+)-[18F]Flubatine als PET-Radiotracer zur Untersuchung von Nikotinrezeptoren bei Demenz (HGF-HVF-0012) (HGF-HVF-0012)

Appears in the scientific report 2022

---

Database coverage:
; ; ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---